Loss of progesterone signaling in the endometrium may be a causal factor in the development of endometriosis, and progesterone resistance is commonly observed in women with this disease. In endometriotic stromal cells, the levels of progesterone receptor (PR), particularly the PR-B isoform, are significantly decreased, leading to a loss of paracrine signaling. PR deficiency likely underlies the development of progesterone resistance in women with endometriosis who no longer respond to progestin therapy. Here we review the complex epigenetic and transcriptional mechanisms leading to PR deficiency. The initial event may involve deficient methylation of the estrogen receptor (ER)beta promoter resulting in pathologic overexpression of ERbeta in endometriotic stromal cells. We speculate that alterations in the relative levels of ERbeta and ERalpha in endometrial tissue dictate E2-regulated PR expression, such that a decreased ERalpha-tauomicron-ERbeta ratio may result in suppression of PR. In this review, we propose a molecular model that may be responsible for changes in ERbeta and ERalpha leading to PR loss and progesterone resistance in endometriosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073375 | PMC |
| http://dx.doi.org/10.1055/s-0029-1242991 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
, an opportunistic gut pathogen, inactivates host gut progesterone and arrests ovarian follicular development.
Gut Microbes
November 2024
Biodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Article Synopsis
- - Levels of progesterone increase after ovulation and are vital for supporting pregnancy, but gut microbiota can influence these levels by affecting the hormone's recycling in the liver and gut.
- - A specific gut bacterium plays a key role in metabolizing progesterone into a neurosteroid, which does not have progestogenic activity; researchers identified the enzyme responsible for this conversion.
- - In experiments with female mice, certain antibiotics helped restore progesterone levels, and prolonged antibiotic use disrupted ovarian follicle development, suggesting a link between gut bacteria and progesterone resistance in women.
Exploring the Role of MicroRNAs in Progesterone and Estrogen Receptor Expression in Endometriosis.
Biomedicines
September 2024
Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Article Synopsis
- The study investigates how specific microRNAs (miRNAs) affect progesterone resistance in endometriosis patients.
- It analyzed samples from 18 control, eutopic, and ectopic groups using next-generation sequencing and qRT-PCR to assess miRNA and receptor expressions.
- Key findings showed that certain miRNAs were upregulated in ectopic tissue and that ERα and ERβ expression levels varied, suggesting that miRNAs may contribute to progesterone resistance and could serve as potential biomarkers or therapeutic targets in endometriosis.
A positive ReceptivaDx result for BCL6 does not correlate with abnormal ERA results or decreased expression of receptivity-associated markers: two sides of the endometrial receptivity coin in fertility evaluation and treatment.
F S Sci
October 2024
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California.
Objective: To investigate if a positive result on ReceptivaDx for evaluation of B-cell lymphoma 6 (BCL6), a proposed marker of progesterone resistance associated with impaired uterine receptivity, correlates with a suboptimal profile of receptivity-associated markers in the window of implantation using the endometrial receptivity array and single-nucleus transcriptomic analysis.
Design: Retrospective clinical cohort study; pilot study of single-nucleus RNA sequencing of prospectively collected window of implantation endometrium undergoing ReceptivaDx BCL6 evaluation.
Setting: Academic center.
Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis.
J Clin Med
August 2024
Gynecology Research Unit, Institute of Experimental and Clinical Research, Université Catholique de Louvain, 1200 Brussels, Belgium.
: While it is known that adenomyosis is associated with poor reproductive outcomes, the underlying mechanisms are unclear, and to date, there is no standard treatment protocol for these patients. Endometrium from adenomyosis patients is characterized by several abnormalities, potentially resulting in impaired receptivity and subsequent implantation failure. : Endometrial biopsies were collected from 26 women with adenomyosis and 26 control subjects.
View Article and Find Full Text PDFEndometriosis in Transgender Men: Bridging Gaps in Research and Care-A Narrative Review.
Biomedicines
July 2024
Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Endometriosis is a debilitating gynecological condition commonly seen in individuals designated female at birth; however, there has been limited research focused on its prevalence and impact among transgender men. This narrative review aims to fill a critical knowledge gap by exploring the epidemiology, clinical manifestations, management strategies, and quality-of-life implications of endometriosis among transgender individuals who identify as male. Specifically, this study seeks to estimate the prevalence rates and describe the symptoms experienced by transgender men undergoing testosterone therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!